ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ARIX Arix Bioscience Plc

142.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Arix Bioscience Plc LSE:ARIX London Ordinary Share GB00BD045071 ORD 0.001P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 142.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Arix Bioscience Plc - Change of Broker

07/11/2019 7:22am

PR Newswire (US)


Arix Bioscience (LSE:ARIX)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Arix Bioscience Charts.

Arix Bioscience plc

Change of Broker

LONDON, 07 November, 2019: Arix Bioscience plc (“Arix”, LSE: ARIX) a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that it has appointed Peel Hunt LLP as joint corporate broker, with immediate effect, alongside its existing corporate broker Jefferies International Limited.

Enquiries

For more information on Arix, please contact:

Arix Bioscience plc

Charlotte Parry, Head of Investor Relations

+44 (0)20 7290 1072

charlotte@arixbioscience.com  

Optimum Strategic Communications

Mary Clark, Supriya Mathur

+44 (0)203 714 1787

optimum.arix@optimumcomms.com

About Arix Bioscience plc

Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences.

We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.

Arix Bioscience plc is listed on the Main Market of the London Stock Exchange. For further information, please visit www.arixbioscience.com

Copyright er 7 PR Newswire

1 Year Arix Bioscience Chart

1 Year Arix Bioscience Chart

1 Month Arix Bioscience Chart

1 Month Arix Bioscience Chart

Your Recent History

Delayed Upgrade Clock